0 XP   0   0   0

Avadel Pharmaceuticals PLC










Financial Health of Avadel




Comparing to competitors in the Drug Manufacturers-Specialty & Generic industry




  Industry Rankings  


Avadel Pharmaceuticals PLC
Buy, Hold or Sell?

Should you buy, hold or sell Avadel?

I guess you are interested in Avadel Pharmaceuticals PLC. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Avadel

Let's start. I'm going to help you getting a better view of Avadel Pharmaceuticals PLC. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Avadel Pharmaceuticals PLC even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Avadel Pharmaceuticals PLC is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Avadel Pharmaceuticals PLC. The closing price on 2022-12-02 was $9.28 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Avadel Pharmaceuticals PLC Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

1.1. Profitability of Avadel Pharmaceuticals PLC.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Avadel earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Avadel to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Avadel Pharmaceuticals PLC:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-15.9%+15.9%
5Y-15.9%10Y-30.5%+14.5%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.4%-0.4%
TTM-0.3%-0.3%
YOY-0.2%-0.2%
5Y-15.9%-0.7%-15.2%
10Y-30.5%-0.1%-30.4%
1.1.2. Return on Assets

Shows how efficient Avadel is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Avadel to the Drug Manufacturers-Specialty & Generic industry mean.
  • -40.2% Return on Assets means that Avadel generated $-0.40 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Avadel Pharmaceuticals PLC:

  • The MRQ is -40.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -17.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-40.2%TTM-17.4%-22.8%
TTM-17.4%YOY-4.7%-12.7%
TTM-17.4%5Y-7.0%-10.4%
5Y-7.0%10Y-4.0%-2.9%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-40.2%0.1%-40.3%
TTM-17.4%0.1%-17.5%
YOY-4.7%-0.1%-4.6%
5Y-7.0%-0.2%-6.8%
10Y-4.0%0.1%-4.1%
1.1.3. Return on Equity

Shows how efficient Avadel is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Avadel to the Drug Manufacturers-Specialty & Generic industry mean.
  • 0.0% Return on Equity means Avadel generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Avadel Pharmaceuticals PLC:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-24.6%+24.6%
TTM-24.6%YOY-10.0%-14.6%
TTM-24.6%5Y-122.6%+97.9%
5Y-122.6%10Y-69.0%-53.5%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.6%-0.6%
TTM-24.6%0.4%-25.0%
YOY-10.0%0.4%-10.4%
5Y-122.6%-0.3%-122.3%
10Y-69.0%0.1%-69.1%

1.2. Operating Efficiency of Avadel Pharmaceuticals PLC.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Avadel is operating .

  • Measures how much profit Avadel makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Avadel to the Drug Manufacturers-Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Avadel Pharmaceuticals PLC:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-13.5%+13.5%
5Y-13.5%10Y-30.8%+17.3%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.5%-2.5%
TTM-1.6%-1.6%
YOY-2.7%-2.7%
5Y-13.5%1.8%-15.3%
10Y-30.8%0.8%-31.6%
1.2.2. Operating Ratio

Measures how efficient Avadel is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Avadel Pharmaceuticals PLC:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.817-0.817
5Y0.81710Y0.994-0.177
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.473-1.473
TTM-1.456-1.456
YOY-1.398-1.398
5Y0.8171.374-0.557
10Y0.9941.191-0.197

1.3. Liquidity of Avadel Pharmaceuticals PLC.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Avadel is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Current Ratio of 2.72 means the company has $2.72 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Avadel Pharmaceuticals PLC:

  • The MRQ is 2.720. The company is able to pay all its short-term debts. +1
  • The TTM is 6.810. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.720TTM6.810-4.090
TTM6.810YOY17.605-10.795
TTM6.8105Y6.931-0.121
5Y6.93110Y4.529+2.402
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7201.880+0.840
TTM6.8101.901+4.909
YOY17.6052.112+15.493
5Y6.9312.182+4.749
10Y4.5291.891+2.638
1.3.2. Quick Ratio

Measures if Avadel is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Avadel to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Quick Ratio of 3.38 means the company can pay off $3.38 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Avadel Pharmaceuticals PLC:

  • The MRQ is 3.382. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 9.874. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.382TTM9.874-6.492
TTM9.874YOY27.401-17.527
TTM9.8745Y10.613-0.739
5Y10.61310Y6.763+3.850
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ3.3820.733+2.649
TTM9.8740.796+9.078
YOY27.4010.808+26.593
5Y10.6130.834+9.779
10Y6.7630.821+5.942

1.4. Solvency of Avadel Pharmaceuticals PLC.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Avadel assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Avadel to Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 1.02 means that Avadel assets are financed with 102.1% credit (debt) and the remaining percentage (100% - 102.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Avadel Pharmaceuticals PLC:

  • The MRQ is 1.021. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 0.770. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ1.021TTM0.770+0.251
TTM0.770YOY0.518+0.253
TTM0.7705Y0.777-0.007
5Y0.77710Y0.803-0.026
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0210.437+0.584
TTM0.7700.424+0.346
YOY0.5180.398+0.120
5Y0.7770.398+0.379
10Y0.8030.401+0.402
1.4.2. Debt to Equity Ratio

Measures if Avadel is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Avadel to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Avadel Pharmaceuticals PLC:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.708-1.708
TTM1.708YOY1.089+0.619
TTM1.7085Y4.886-3.178
5Y4.88610Y4.479+0.407
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.652-0.652
TTM1.7080.675+1.033
YOY1.0890.623+0.466
5Y4.8860.684+4.202
10Y4.4790.697+3.782

2. Market Valuation of Avadel Pharmaceuticals PLC

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Avadel generates.

  • Above 15 is considered overpriced but always compare Avadel to the Drug Manufacturers-Specialty & Generic industry mean.
  • A PE ratio of -2.33 means the investor is paying $-2.33 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Avadel Pharmaceuticals PLC:

  • The EOD is -8.861. Company is losing money. -2
  • The MRQ is -2.330. Company is losing money. -2
  • The TTM is -16.731. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-8.861MRQ-2.330-6.531
MRQ-2.330TTM-16.731+14.401
TTM-16.731YOY-30.882+14.151
TTM-16.7315Y-57.252+40.521
5Y-57.25210Y-34.656-22.595
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD-8.861-0.124-8.737
MRQ-2.330-0.437-1.893
TTM-16.731-0.102-16.629
YOY-30.88215.340-46.222
5Y-57.2527.916-65.168
10Y-34.6567.700-42.356
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Avadel.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Avadel Pharmaceuticals PLC:

  • The MRQ is 3.993. Seems overpriced? -1
  • The TTM is 496.673. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ3.993TTM496.673-492.680
TTM496.673YOY-156.271+652.943
TTM496.6735Y100.087+396.586
5Y100.08710Y580.792-480.705
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ3.9930.012+3.981
TTM496.6730.010+496.663
YOY-156.2710.004-156.275
5Y100.0870.010+100.077
10Y580.7920.021+580.771

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Avadel is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A PB ratio of -44.36 means the investor is paying $-44.36 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Avadel Pharmaceuticals PLC:

  • The EOD is -168.726. Bad. Book ratio is negative. -2
  • The MRQ is -44.363. Bad. Book ratio is negative. -2
  • The TTM is -6.154. Bad. Book ratio is negative. -2
Trends
Current periodCompared to+/- 
EOD-168.726MRQ-44.363-124.363
MRQ-44.363TTM-6.154-38.209
TTM-6.154YOY2.930-9.084
TTM-6.1545Y2.186-8.340
5Y2.18610Y8.744-6.559
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD-168.7261.415-170.141
MRQ-44.3631.586-45.949
TTM-6.1542.019-8.173
YOY2.9302.230+0.700
5Y2.1861.895+0.291
10Y8.7441.505+7.239
2. Total Gains per Share

2.4. Latest News of Avadel Pharmaceuticals PLC

Does Avadel Pharmaceuticals PLC still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Avadel Pharmaceuticals PLC to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2022-11-26
13:49
Avadel Pharmaceuticals plc (NASDAQ:AVDL) insiders placed bullish bets worth US$677k in the last 12 monthsRead
2022-11-09
13:30
Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2022 Financial ResultsRead

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Avadel Pharmaceuticals PLC.

3.1. Institutions holding Avadel Pharmaceuticals PLC

Institutions are holding 57.284% of the shares of Avadel Pharmaceuticals PLC.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-06-30RTW INVESTMENTS, LLC9.47810.362574193900
2022-06-30Gendell Jeffrey L7.02971.20044258696142126550.0899
2022-06-30COWEN AND COMPANY, LLC6.16160.8796373277800
2022-06-30Brandes Investment Partners & Co5.99440.2163363147564280021.5079
2022-06-30Vivo Capital, LLC4.84820.7197293709300
2022-06-30Polar Capital Holdings PLC4.64250.04032812490-386662-12.0864
2022-06-30WEALTH EFFECTS LLC4.26553.794825840902068008.699
2022-06-30Woodline Partners LP2.61680.05961585292-530737-25.0817
2022-06-30Renaissance Technologies Corp1.40970.00258540069970013.2174
2022-06-30PURA VIDA INVESTMENTS, LLC1.30270.11197891817891810
2022-06-30Samsara BioCapital, LLC1.08850.428965940900
2022-09-30Modera Wealth Management, LLC0.90130.138554600012300029.078
2022-06-30Two Sigma Investments LLC0.77340.00384685594685590
2022-06-30MPM Oncology Impact Management LP0.68070.279541236300
2022-06-30Millennium Management LLC0.35090.00032125902125900
2022-06-30State Street Corporation0.28380171952-33842-16.4446
2022-06-30Atlantic Trust Group, LLC0.27240.00111650055893455.5609
2022-06-30Citadel Advisors Llc0.26590.00011610627436585.7757
2022-09-30Edge Wealth Management, LLC0.25750.175815600000
2022-06-30Lazard Asset Management LLC0.23530.0005142577-3565-2.4394
Total 52.85898.415632022557+3142388+9.8%

3.2. Funds holding Avadel Pharmaceuticals PLC

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-09-30Polar Capital Healthcare Opports Inc4.64250.8765281249000
2022-09-30Brandes European Value I USD1.11851.1871677593-63867-8.6137
2022-09-30Brandes International Small Cap Eq0.82450.9001499487-242798-32.7095
2022-09-30Brandes International Small Cap Equity A0.56420.7295341796-105791-23.6359
2022-10-31Brandes Global Small Cap Equity Cl F0.28610.5639173333-24964-12.5892
2022-09-30Brandes Global Small Cap Eq0.11910.45637213500
2022-09-30DWS Small Cap Core S0.11140.080367482-57518-46.0144
2022-06-30International Biotechnology Ord0.08250.03565000000
2022-09-30Fidelity® NASDAQ Composite Index®0.06690.00214052800
2022-05-31Vifag 2002 SICAV0.04950.127830000-172-0.5701
2022-10-31iShares Nasdaq US Biotech ETF USD Acc0.04620.03972797600
2022-10-31SPDR® S&P International Small Cap ETF0.0390.0252362300
2022-09-30Franklin K2 Alternative Strategies R60.02940.008717800176229900
2022-09-30Brandes European Equity0.02721.091716479-4091-19.8882
2022-09-30Brandes U.S. Small Cap Value Equity HNW0.02391.203614489138562188.9415
2022-09-30Brandes U.S. Small Cap Value Equity0.02391.203614489-8505-36.9879
2022-08-31Inver-99 SICAV0.00992.1284600000
2022-09-30Brandes Small Cap Value R60.00890.68635365-4822-47.3348
2022-07-31ProShares Ultra Nasdaq Biotechnology0.00820.022549643738.1246
2022-09-30LUX IM Global Medtech HX0.00590.0072360000
Total 8.087711.37594899629-480677-9.8%

3.3. Insider Transactions

Insiders are holding 7.047% of the shares of Avadel Pharmaceuticals PLC.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-05-31Eric J EndeBUY150002.16114900
2022-05-27Linda PalczukBUY100001.647900
2022-05-27Thomas S MchughBUY500002.1471500
2020-09-18Thomas S MchughBUY4000621500
2020-09-16Mark Anthony MccamishBUY1186025.73
2020-08-14Linda PalczukBUY25007.94
2020-08-13Thomas S MchughBUY100007.7810000
2020-08-12Eric J. EndeBUY150007.76
2020-08-12Gregory J. DivisBUY130007.78
2019-12-12Sandra L HattenSELL30727.2355765
2019-12-04Eric J EndeBUY100005.76 
2019-11-18Geoffrey Michael GlassBUY200005.3 
2019-11-15Eric J EndeBUY100005.32 
2019-11-15Greg J DivisBUY190005.32 
2018-12-14Sandra L. HattenSELL31732.58
2018-08-10Michael S. AndersonSELL162974.91
2018-08-10Sandra L. HattenSELL62904.91
2018-06-26Michael S. AndersonBUY25006.04
2018-06-25James E. FlynnSELL1140345.99
2018-05-24Michael S. AndersonBUY30006.44

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Avadel Pharmaceuticals PLC compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.967-0.504-48%-0.160-83%-0.066-93%-0.012-99%
Book Value Growth---17.576-4.615-74%-0.114-99%-2.060-88%-1.116-94%
Book Value Per Share---0.0550.945-106%2.430-102%1.106-105%0.840-107%
Book Value Per Share Growth---17.576-4.615-74%-0.078-100%-2.055-88%-1.113-94%
Current Ratio--2.7206.810-60%17.605-85%6.931-61%4.529-40%
Debt To Asset Ratio--1.0210.770+33%0.518+97%0.777+31%0.803+27%
Debt To Equity Ratio---1.708-100%1.089-100%4.886-100%4.479-100%
Dividend Per Share----0%-0%-0%-0%
Eps---1.047-0.554-47%-0.231-78%-0.231-78%-0.167-84%
Eps Growth---0.584-0.216-63%-0.930+59%0.099-691%0.114-610%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin----0%-0%-0.1590%-0.3050%
Operating Margin----0%-0%-0.1350%-0.3080%
Operating Ratio----0%-0%0.817-100%0.994-100%
Pb Ratio-168.726-280%-44.363-6.154-86%2.930-1614%2.186-2130%8.744-607%
Pe Ratio-8.861-280%-2.330-16.731+618%-30.882+1225%-57.252+2357%-34.656+1387%
Peg Ratio--3.993496.673-99%-156.271+4014%100.087-96%580.792-99%
Price Per Share9.280+74%2.4406.788-64%6.873-64%6.290-61%8.769-72%
Price To Total Gains Ratio-9.600-280%-2.524-18.484+632%-16.747+563%-8.514+237%-20.675+719%
Profit Growth---58.351-21.575-63%-101.875+75%8.080-822%25.972-325%
Quick Ratio--3.3829.874-66%27.401-88%10.613-68%6.763-50%
Return On Assets---0.402-0.174-57%-0.047-88%-0.070-83%-0.040-90%
Return On Equity----0.2460%-0.1000%-1.2260%-0.6900%
Total Gains Per Share---0.967-0.504-48%-0.160-83%-0.066-93%-0.012-99%
Total Gains Per Share Growth---0.607-0.215-65%-2.760+355%0.031-2060%0.291-308%
Usd Book Value---3332000.00057275250.000-106%147212500.000-102%68239350.000-105%51502200.000-106%
Usd Book Value Change Per Share---0.967-0.504-48%-0.160-83%-0.066-93%-0.012-99%
Usd Book Value Per Share---0.0550.945-106%2.430-102%1.106-105%0.840-107%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---1.047-0.554-47%-0.231-78%-0.231-78%-0.167-84%
Usd Price Per Share9.280+74%2.4406.788-64%6.873-64%6.290-61%8.769-72%
Usd Profit---63444000.000-33542750.000-47%-14001750.000-78%-13763250.000-78%-6601100.000-90%
Usd Revenue----0%-0%12962250.000-100%18464900.000-100%
Usd Total Gains Per Share---0.967-0.504-48%-0.160-83%-0.066-93%-0.012-99%
 EOD+3 -2MRQTTM+5 -21YOY+7 -195Y+6 -2210Y+6 -22

4.2. Fundamental Score

Let's check the fundamental score of Avadel Pharmaceuticals PLC based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-8.861
Price to Book Ratio (EOD)Between0-1-168.726
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than13.382
Current Ratio (MRQ)Greater than12.720
Debt to Asset Ratio (MRQ)Less than11.021
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.402
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Avadel Pharmaceuticals PLC based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5064.515
Ma 20Greater thanMa 507.671
Ma 50Greater thanMa 1006.568
Ma 100Greater thanMa 2006.185
OpenGreater thanClose9.420
Total5/5 (100.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2021-06-302021-09-302021-12-312022-03-312022-06-30
Total Stockholder Equity 118,880-19,92398,957-20,71378,244-23,01255,232-58,564-3,332
Net Tangible Assets  102,039-19,92382,116-20,71361,403-23,01238,391-58,564-20,173
Tax Provision  -3,765-1,336-5,101758-4,34320-4,32334,51630,193
Income Tax Expense  -3,765-1,336-5,101758-4,34320-4,32334,51630,193



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets157,938
Total Liabilities161,270
Total Stockholder Equity-3,332
 As reported
Total Liabilities 161,270
Total Stockholder Equity+ -3,332
Total Assets = 157,938

Assets

Total Assets157,938
Total Current Assets125,713
Long-term Assets125,713
Total Current Assets
Cash And Cash Equivalents 54,128
Short-term Investments 49,993
Net Receivables 2,205
Other Current Assets 21,592
Total Current Assets  (as reported)125,713
Total Current Assets  (calculated)127,918
+/- 2,205
Long-term Assets
Property Plant Equipment 2,432
Goodwill 16,836
Other Assets 12,957
Long-term Assets  (as reported)32,225
Long-term Assets  (calculated)32,225
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities46,217
Long-term Liabilities115,053
Total Stockholder Equity-3,332
Total Current Liabilities
Short-term Debt 27,173
Short Long Term Debt 26,241
Accounts payable 7,318
Other Current Liabilities 11,726
Total Current Liabilities  (as reported)46,217
Total Current Liabilities  (calculated)72,458
+/- 26,241
Long-term Liabilities
Long term Debt Total 108,074
Capital Lease Obligations 2,195
Other Liabilities 5,716
Long-term Liabilities  (as reported)115,053
Long-term Liabilities  (calculated)115,985
+/- 932
Total Stockholder Equity
Common Stock590
Retained Earnings -537,624
Accumulated Other Comprehensive Income -26,328
Capital Surplus 560,025
Total Stockholder Equity (as reported)-3,332
Total Stockholder Equity (calculated)-3,337
+/- 5
Other
Capital Stock595
Cash and Short Term Investments 104,121
Common Stock Shares Outstanding 59,037
Common Stock Total Equity590
Liabilities and Stockholders Equity 157,938
Net Debt 82,382
Net Invested Capital 130,978
Net Tangible Assets -20,173
Net Working Capital 79,496
Preferred Stock Total Equity 5
Short Long Term Debt Total 136,510



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-31
> Total Assets 
4,700
0
0
29,900
0
0
0
21,500
18,900
0
0
25,318
0
0
0
14,920
12,865
23,131
20,531
20,360
17,376
0
15,598
18,144
0
0
21,674
23,076
23,580
23,856
33,022
127,252
127,590
124,230
124,230
145,608
145,950
142,585
127,972
124,351
116,278
113,648
111,262
114,894
108,461
106,435
103,911
101,401
105,197
101,091
88,767
91,861
91,080
93,253
97,921
94,296
81,255
70,480
77,384
74,614
69,980
76,114
72,697
69,402
137,411
133,715
0
117,311
122,733
118,408
116,514
116,252
181,743
174,631
164,385
174,207
186,410
186,546
0
214,977
214,977
249,706
247,985
245,482
258,688
259,160
277,427
253,277
351,861
295,236
269,006
190,300
173,622
165,709
155,888
151,436
207,725
341,401
327,635
311,637
292,941
282,591
264,089
247,265
221,127
157,938
157,938221,127247,265264,089282,591292,941311,637327,635341,401207,725151,436155,888165,709173,622190,300269,006295,236351,861253,277277,427259,160258,688245,482247,985249,706214,977214,9770186,546186,410174,207164,385174,631181,743116,252116,514118,408122,733117,3110133,715137,41169,40272,69776,11469,98074,61477,38470,48081,25594,29697,92193,25391,08091,86188,767101,091105,197101,401103,911106,435108,461114,894111,262113,648116,278124,351127,972142,585145,950145,608124,230124,230127,590127,25233,02223,85623,58023,07621,6740018,14415,598017,37620,36020,53123,13112,86514,92000025,3180018,90021,50000029,900004,700
   > Total Current Assets 
2,500
0
0
17,800
0
0
0
14,600
11,800
0
0
16,436
0
0
0
7,752
0
0
0
14,061
0
0
0
13,799
0
0
18,256
18,711
19,218
19,662
28,588
120,735
117,848
111,066
111,066
120,772
123,421
116,786
101,604
91,988
83,708
80,037
78,750
76,779
68,148
62,668
61,605
56,110
56,977
52,265
49,601
59,189
59,192
59,002
69,239
66,841
56,780
47,223
50,246
45,362
36,913
41,989
40,023
36,652
32,604
30,282
0
25,085
39,244
34,949
32,931
33,623
108,725
105,121
99,248
112,322
129,334
132,167
0
166,306
166,306
177,648
177,854
181,186
204,612
204,351
148,933
123,975
231,933
174,976
147,876
124,851
102,437
97,200
88,602
82,380
130,975
277,019
281,688
263,454
242,314
230,702
205,820
192,490
160,741
125,713
125,713160,741192,490205,820230,702242,314263,454281,688277,019130,97582,38088,60297,200102,437124,851147,876174,976231,933123,975148,933204,351204,612181,186177,854177,648166,306166,3060132,167129,334112,32299,248105,121108,72533,62332,93134,94939,24425,085030,28232,60436,65240,02341,98936,91345,36250,24647,22356,78066,84169,23959,00259,19259,18949,60152,26556,97756,11061,60562,66868,14876,77978,75080,03783,70891,988101,604116,786123,421120,772111,066111,066117,848120,73528,58819,66219,21818,71118,2560013,79900014,0610007,75200016,4360011,80014,60000017,800002,500
       Cash And Cash Equivalents 
1,200
0
0
15,500
0
0
0
3,800
6,000
0
0
7,277
0
0
0
5,210
0
0
0
10,137
0
0
0
5,309
0
0
14,623
14,527
14,319
11,649
22,076
109,617
105,435
100,850
100,850
4,591
1,332
914
1,606
1,018
2,598
5,544
564
51,827
44,444
36,820
29,538
26,313
31,608
22,701
28,405
27,021
17,853
7,205
4,784
8,716
995
3,570
3,909
8,184
5,831
11,584
6,729
3,456
4,348
4,755
0
2,742
14,010
8,336
7,807
6,636
55,505
54,104
24,006
39,760
38,535
55,236
0
65,064
65,064
23,899
18,780
39,215
32,236
43,507
37,449
16,564
40,911
12,477
17,837
9,325
9,630
17,111
12,867
9,774
73,506
102,174
83,109
71,722
59,172
67,142
58,169
50,708
60,873
54,128
54,12860,87350,70858,16967,14259,17271,72283,109102,17473,5069,77412,86717,1119,6309,32517,83712,47740,91116,56437,44943,50732,23639,21518,78023,89965,06465,064055,23638,53539,76024,00654,10455,5056,6367,8078,33614,0102,74204,7554,3483,4566,72911,5845,8318,1843,9093,5709958,7164,7847,20517,85327,02128,40522,70131,60826,31329,53836,82044,44451,8275645,5442,5981,0181,6069141,3324,591100,850100,850105,435109,61722,07611,64914,31914,52714,623005,30900010,1370005,2100007,277006,0003,80000015,500001,200
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
108,418
0
0
0
100,783
107,497
101,680
87,812
82,756
72,608
63,598
66,015
10,944
8,274
10,145
11,218
14,749
7,670
11,787
4,414
10,057
21,209
37,862
44,026
35,352
34,377
30,155
28,132
23,160
20,172
21,395
22,728
21,035
18,376
15,686
0
6,413
1,358
1,387
1,473
401
28,018
23,753
52,496
53,074
74,637
60,884
0
79,738
79,738
130,964
130,887
114,980
146,978
130,290
78,161
77,511
157,269
134,629
107,425
90,590
70,221
62,151
59,587
54,384
39,977
136,380
148,467
149,680
145,803
135,701
122,924
106,513
62,608
49,993
49,99362,608106,513122,924135,701145,803149,680148,467136,38039,97754,38459,58762,15170,22190,590107,425134,629157,26977,51178,161130,290146,978114,980130,887130,96479,73879,738060,88474,63753,07452,49623,75328,0184011,4731,3871,3586,413015,68618,37621,03522,72821,39520,17223,16028,13230,15534,37735,35244,02637,86221,20910,0574,41411,7877,67014,74911,21810,1458,27410,94466,01563,59872,60882,75687,812101,680107,497100,783000108,4180000000000000000000000000000000
       Net Receivables 
500
0
0
1,000
0
0
0
3,300
1,300
0
0
3,195
0
0
0
1,611
0
0
0
2,641
0
0
0
7,596
0
0
2,938
3,462
3,503
6,008
4,347
8,367
7,754
5,212
5,212
8,203
8,458
7,255
6,238
2,583
3,207
5,928
7,767
8,988
6,497
7,553
13,052
12,139
12,306
12,015
12,465
18,093
15,755
8,686
15,234
18,075
15,958
8,302
12,580
9,784
7,485
5,875
6,282
7,844
5,580
5,570
0
13,109
20,231
21,583
17,826
21,032
18,079
18,869
12,893
8,688
5,378
5,107
0
13,985
13,985
14,084
18,219
19,026
15,310
20,932
25,725
16,509
18,229
16,696
11,447
13,912
14,138
12,110
10,396
11,975
11,425
33,607
46,754
38,782
30,451
21,692
21,282
2,443
31,509
2,205
2,20531,5092,44321,28221,69230,45138,78246,75433,60711,42511,97510,39612,11014,13813,91211,44716,69618,22916,50925,72520,93215,31019,02618,21914,08413,98513,98505,1075,3788,68812,89318,86918,07921,03217,82621,58320,23113,10905,5705,5807,8446,2825,8757,4859,78412,5808,30215,95818,07515,2348,68615,75518,09312,46512,01512,30612,13913,0527,5536,4978,9887,7675,9283,2072,5836,2387,2558,4588,2035,2125,2127,7548,3674,3476,0083,5033,4622,938007,5960002,6410001,6110003,195001,3003,3000001,00000500
       Inventory 
200
0
0
200
0
0
0
100
200
0
0
804
0
0
0
186
447
454
666
860
695
0
810
569
0
0
351
375
531
1,069
545
1,057
991
1,310
1,310
1,597
1,129
966
1,171
1,050
974
1,265
1,354
3,332
3,077
3,064
2,948
1,771
2,218
2,194
1,683
1,837
2,093
2,592
2,157
1,072
826
932
1,070
862
854
906
1,699
1,675
1,903
1,599
0
1,520
1,884
1,854
2,892
3,762
5,132
5,564
6,473
6,729
5,497
5,751
0
4,155
4,155
3,640
3,909
3,258
5,406
5,747
5,870
6,157
5,948
5,724
6,030
4,770
4,258
2,601
2,260
3,570
3,523
0
0
0
0
0
0
0
0
0
0000000003,5233,5702,2602,6014,2584,7706,0305,7245,9486,1575,8705,7475,4063,2583,9093,6404,1554,15505,7515,4976,7296,4735,5645,1323,7622,8921,8541,8841,52001,5991,9031,6751,6999068548621,0709328261,0722,1572,5922,0931,8371,6832,1942,2181,7712,9483,0643,0773,3321,3541,2659741,0501,1719661,1291,5971,3101,3109911,0575451,0695313753510056981006958606664544471860008040020010000020000200
       Other Current Assets 
600
0
0
1,100
0
0
0
7,400
4,300
0
0
5,160
0
0
0
745
741
738
318
423
532
0
469
325
0
0
344
347
865
936
1,620
1,694
3,668
3,694
3,694
5,598
5,005
5,971
4,777
4,581
4,321
3,702
3,050
1,688
5,856
5,086
4,849
1,138
3,175
3,568
2,634
2,181
2,282
2,657
3,038
3,626
4,624
4,264
4,555
3,372
2,571
2,229
2,585
2,642
2,397
2,672
0
1,301
1,761
1,789
2,933
1,792
1,991
2,831
3,380
4,071
5,287
5,189
0
44,687
3,364
5,061
6,059
4,707
4,682
3,875
1,728
7,234
9,576
5,450
5,137
6,254
4,190
3,227
3,492
2,677
2,544
4,858
3,358
3,270
6,888
6,167
3,445
35,269
5,751
21,592
21,5925,75135,2693,4456,1676,8883,2703,3584,8582,5442,6773,4923,2274,1906,2545,1375,4509,5767,2341,7283,8754,6824,7076,0595,0613,36444,68705,1895,2874,0713,3802,8311,9911,7922,9331,7891,7611,30102,6722,3972,6422,5852,2292,5713,3724,5554,2644,6243,6263,0382,6572,2822,1812,6343,5683,1751,1384,8495,0865,8561,6883,0503,7024,3214,5814,7775,9715,0055,5983,6943,6943,6681,6941,6209368653473440032546905324233187387417450005,160004,3007,4000001,10000600
   > Long-term Assets 
2,200
0
0
12,100
0
0
0
6,900
7,100
0
0
8,882
0
0
0
7,168
0
0
0
6,299
0
0
0
4,345
0
0
3,418
4,365
4,362
4,194
4,434
6,517
9,742
13,164
13,164
24,836
22,529
25,799
26,368
32,363
32,570
33,611
32,512
38,115
40,313
43,767
42,306
45,291
48,220
48,826
39,166
32,672
31,888
34,251
28,682
27,455
24,475
23,257
27,138
29,252
33,067
34,125
32,674
32,750
104,807
103,433
0
92,226
83,489
83,459
83,583
82,629
73,018
69,510
65,137
61,885
57,076
54,379
0
2,616
48,671
72,058
70,131
64,296
54,076
54,809
128,494
129,302
119,928
120,260
121,130
65,449
71,185
68,509
67,286
69,056
76,750
64,382
45,947
48,183
50,627
51,889
58,269
54,775
60,386
32,225
32,22560,38654,77558,26951,88950,62748,18345,94764,38276,75069,05667,28668,50971,18565,449121,130120,260119,928129,302128,49454,80954,07664,29670,13172,05848,6712,616054,37957,07661,88565,13769,51073,01882,62983,58383,45983,48992,2260103,433104,80732,75032,67434,12533,06729,25227,13823,25724,47527,45528,68234,25131,88832,67239,16648,82648,22045,29142,30643,76740,31338,11532,51233,61132,57032,36326,36825,79922,52924,83613,16413,1649,7426,5174,4344,1944,3624,3653,418004,3450006,2990007,1680008,882007,1006,90000012,100002,200
       Property Plant Equipment 
1,100
0
0
1,700
0
0
0
4,100
4,300
0
0
4,618
0
0
0
3,502
3,292
3,177
2,742
2,922
2,722
0
2,706
2,672
0
0
3,095
3,405
3,342
3,431
3,658
5,085
8,331
11,747
11,747
18,162
16,108
19,863
20,460
22,317
22,262
23,433
22,376
25,705
27,739
31,013
34,201
35,140
36,115
34,473
29,890
27,601
25,065
25,734
25,936
24,759
22,547
20,438
22,677
21,425
22,744
22,462
20,409
19,383
19,645
18,041
0
18,238
17,271
17,271
17,352
17,435
17,170
16,605
15,182
1,777
1,777
1,978
0
2,616
2,616
3,104
3,186
3,320
3,382
3,328
3,180
3,001
2,722
7,315
8,248
7,805
13,378
12,949
11,649
10,584
10,199
8,725
8,440
8,164
8,321
8,319
9,445
2,937
12,760
2,432
2,43212,7602,9379,4458,3198,3218,1648,4408,72510,19910,58411,64912,94913,3787,8058,2487,3152,7223,0013,1803,3283,3823,3203,1863,1042,6162,61601,9781,7771,77715,18216,60517,17017,43517,35217,27117,27118,238018,04119,64519,38320,40922,46222,74421,42522,67720,43822,54724,75925,93625,73425,06527,60129,89034,47336,11535,14034,20131,01327,73925,70522,37623,43322,26222,31720,46019,86316,10818,16211,74711,7478,3315,0853,6583,4313,3423,4053,095002,6722,70602,7222,9222,7423,1773,2923,5020004,618004,3004,1000001,700001,100
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,461
20,461
0
18,491
18,491
18,491
18,490
18,491
18,491
18,491
18,490
18,491
18,491
18,491
0
18,491
18,491
18,669
19,134
18,491
18,491
18,491
18,491
18,491
18,491
18,491
18,491
18,491
18,491
18,491
18,491
18,491
18,491
16,836
16,836
16,836
16,836
16,836
16,836
16,836
16,836
16,836
16,83616,83616,83616,83616,83616,83616,83616,83616,83618,49118,49118,49118,49118,49118,49118,49118,49118,49118,49118,49118,49118,49118,49119,13418,66918,49118,491018,49118,49118,49118,49018,49118,49118,49118,49018,49118,49118,491020,46120,4610000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
300
0
0
200
0
0
0
100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
49,250
49,089
0
41,589
41,424
41,259
41,094
40,139
37,202
34,264
31,326
28,390
25,249
22,108
0
15,825
15,825
29,209
25,508
22,837
22,274
21,709
94,256
92,289
72,571
70,962
69,339
1,629
1,428
1,224
1,019
813
610
0
0
0
0
0
0
0
0
0
0000000006108131,0191,2241,4281,62969,33970,96272,57192,28994,25621,70922,27422,83725,50829,20915,82515,825022,10825,24928,39031,32634,26437,20240,13941,09441,25941,42441,589049,08949,2500000000000000000000000000000000000000000000000000000000010000020000300
       Long-term Assets Other 
800
0
0
10,200
0
0
0
2,700
2,800
0
0
4,264
0
0
0
3,666
0
0
0
3,377
0
0
0
1,673
0
0
323
960
1,020
763
776
1,432
1,411
1,417
1,417
6,674
6,421
5,936
5,908
10,046
10,308
10,178
10,136
12,410
12,574
12,754
8,105
10,151
12,105
14,353
9,276
5,071
6,823
8,517
2,746
2,696
1,928
2,819
4,461
7,827
10,323
11,663
12,265
13,203
15,276
15,669
0
13,908
6,303
6,438
6,647
6,564
155
150
139
125
115
117
0
158
158
4,153
4,345
1,874
2,497
4,171
5,457
11,644
19,416
17,028
16,939
14,495
14,672
14,773
14,491
9,741
9,590
9,641
5,192
4,927
4,680
2,250
-120,734
-71,511
2,212
12,957
12,9572,212-71,511-120,7342,2504,6804,9275,1929,6419,5909,74114,49114,77314,67214,49516,93917,02819,41611,6445,4574,1712,4971,8744,3454,15315815801171151251391501556,5646,6476,4386,30313,908015,66915,27613,20312,26511,66310,3237,8274,4612,8191,9282,6962,7468,5176,8235,0719,27614,35312,10510,1518,10512,75412,57412,41010,13610,17810,30810,0465,9085,9366,4216,6741,4171,4171,4111,4327767631,020960323001,6730003,3770003,6660004,264002,8002,70000010,20000800
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,342
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000010,34200000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
6,200
0
0
6,800
0
0
0
7,200
7,500
0
0
7,533
0
0
0
5,853
10,322
9,402
8,593
9,478
7,769
0
7,750
10,635
0
0
9,716
10,790
12,511
13,215
12,543
35,191
33,584
31,457
31,457
28,851
28,997
37,478
33,447
37,697
33,783
34,274
39,342
41,868
40,443
47,450
48,479
46,774
47,873
44,231
38,104
43,315
42,036
43,300
47,851
49,433
42,345
38,116
43,916
38,309
35,961
44,220
40,334
39,608
105,426
108,354
0
86,807
101,051
128,472
131,919
125,764
103,614
116,768
124,337
149,312
164,164
172,909
0
147,112
147,112
197,868
211,152
203,413
199,606
182,432
180,964
167,697
264,807
216,690
203,264
187,520
183,204
183,486
182,851
180,635
175,658
159,276
156,435
149,371
156,437
163,711
165,132
169,021
165,895
161,270
161,270165,895169,021165,132163,711156,437149,371156,435159,276175,658180,635182,851183,486183,204187,520203,264216,690264,807167,697180,964182,432199,606203,413211,152197,868147,112147,1120172,909164,164149,312124,337116,768103,614125,764131,919128,472101,05186,8070108,354105,42639,60840,33444,22035,96138,30943,91638,11642,34549,43347,85143,30042,03643,31538,10444,23147,87346,77448,47947,45040,44341,86839,34234,27433,78337,69733,44737,47828,99728,85131,45731,45733,58435,19112,54313,21512,51110,7909,7160010,6357,75007,7699,4788,5939,40210,3225,8530007,533007,5007,2000006,800006,200
   > Total Current Liabilities 
4,400
0
0
4,800
0
0
0
4,100
4,500
0
0
4,353
0
0
0
3,495
8,155
7,305
6,739
6,113
5,001
0
4,901
6,461
0
0
5,509
6,509
7,161
7,796
7,868
17,868
19,376
18,980
18,980
23,326
23,449
30,490
21,580
24,896
20,326
19,266
20,015
21,314
19,740
25,024
27,024
24,955
25,612
22,305
18,548
20,255
19,361
16,204
21,484
22,896
20,496
18,478
24,362
19,421
18,461
18,910
17,642
18,314
17,176
16,244
0
14,359
13,516
17,102
33,607
40,595
37,297
37,841
47,720
70,842
77,652
52,749
0
48,788
48,788
58,188
59,185
62,421
84,049
88,709
97,308
86,539
87,185
51,613
47,019
38,383
31,358
33,580
31,763
35,984
32,336
27,018
23,009
15,109
9,120
16,280
17,587
21,000
44,023
46,217
46,21744,02321,00017,58716,2809,12015,10923,00927,01832,33635,98431,76333,58031,35838,38347,01951,61387,18586,53997,30888,70984,04962,42159,18558,18848,78848,788052,74977,65270,84247,72037,84137,29740,59533,60717,10213,51614,359016,24417,17618,31417,64218,91018,46119,42124,36218,47820,49622,89621,48416,20419,36120,25518,54822,30525,61224,95527,02425,02419,74021,31420,01519,26620,32624,89621,58030,49023,44923,32618,98018,98019,37617,8687,8687,7967,1616,5095,509006,4614,90105,0016,1136,7397,3058,1553,4950004,353004,5004,1000004,800004,400
       Short-term Debt 
200
0
0
400
0
0
0
400
400
0
0
397
0
0
0
538
0
0
0
643
0
0
0
781
0
0
677
922
290
289
241
257
354
231
231
552
593
369
571
828
755
795
795
420
377
336
301
980
991
931
805
753
680
754
749
895
838
764
2,192
2,376
2,557
2,374
2,225
2,123
2,180
2,056
0
3,428
3,328
6,875
20,447
19,279
18,132
18,124
27,888
42,345
44,632
37,803
0
434
434
283
286
268
272
291
301
111
114
108
107
106
1,086
1,104
1,631
645
604
563
520
474
484
494
504
900
27,101
27,173
27,17327,1019005044944844745205636046451,6311,1041,086106107108114111301291272268286283434434037,80344,63242,34527,88818,12418,13219,27920,4476,8753,3283,42802,0562,1802,1232,2252,3742,5572,3762,192764838895749754680753805931991980301336377420795795755828571369593552231231354257241289290922677007810006430005380003970040040000040000200
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
98,779
0
0
0
7,822
0
0
0
434
0
0
0
268
272
885
301
111
114
108
107
106
104
105
35
0
0
0
0
0
0
0
0
0
26,184
26,241
26,24126,184000000000351051041061071081141113018852722680004340007,82200098,77900000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
2,000
0
0
3,100
0
0
0
2,500
2,800
0
0
2,598
0
0
0
1,519
0
1,544
1,481
1,540
1,487
0
1,182
1,205
0
0
1,064
1,322
2,184
2,388
2,357
4,397
7,020
6,961
6,961
9,660
7,811
15,486
11,069
11,497
9,023
7,400
6,941
9,702
10,252
13,071
12,933
8,568
8,306
7,303
4,912
5,760
5,299
4,272
4,899
6,366
5,169
5,262
5,156
4,941
4,705
3,982
3,432
3,920
4,675
4,758
0
3,596
3,425
3,268
4,115
5,099
6,358
6,167
7,007
8,024
9,037
11,403
0
18,047
10,565
7,043
8,966
7,105
7,962
12,321
8,564
7,477
15,906
11,169
11,399
3,503
4,150
4,798
3,538
6,100
6,790
4,879
2,660
2,934
2,824
5,116
6,874
7,679
6,048
7,318
7,3186,0487,6796,8745,1162,8242,9342,6604,8796,7906,1003,5384,7984,1503,50311,39911,16915,9067,4778,56412,3217,9627,1058,9667,04310,56518,047011,4039,0378,0247,0076,1676,3585,0994,1153,2683,4253,59604,7584,6753,9203,4323,9824,7054,9415,1565,2625,1696,3664,8994,2725,2995,7604,9127,3038,3068,56812,93313,07110,2529,7026,9417,4009,02311,49711,06915,4867,8119,6606,9616,9617,0204,3972,3572,3882,1841,3221,064001,2051,18201,4871,5401,4811,54401,5190002,598002,8002,5000003,100002,000
       Other Current Liabilities 
2,200
0
0
1,300
0
0
0
1,200
1,300
0
0
1,358
0
0
0
1,438
7,927
5,241
4,783
2,367
2,905
0
3,173
3,403
0
0
2,064
2,460
2,155
2,293
3,001
3,591
3,032
3,211
3,211
10,586
14,043
13,840
8,114
12,389
10,548
10,924
11,542
10,630
8,783
11,481
13,206
12,459
13,896
12,252
11,412
12,944
11,710
9,527
11,370
11,773
10,876
9,402
14,485
9,576
8,888
8,283
7,941
7,473
6,933
6,506
0
6,146
6,066
6,322
7,592
14,837
12,650
12,552
12,213
19,137
20,438
3,522
0
128,631
32,668
47,042
46,818
52,825
74,198
73,642
86,516
76,944
69,281
38,612
33,793
34,660
26,007
27,678
26,594
29,239
24,942
21,576
19,829
11,701
5,812
10,670
10,209
12,421
10,874
11,726
11,72610,87412,42110,20910,6705,81211,70119,82921,57624,94229,23926,59427,67826,00734,66033,79338,61269,28176,94486,51673,64274,19852,82546,81847,04232,668128,63103,52220,43819,13712,21312,55212,65014,8377,5926,3226,0666,14606,5066,9337,4737,9418,2838,8889,57614,4859,40210,87611,77311,3709,52711,71012,94411,41212,25213,89612,45913,20611,4818,78310,63011,54210,92410,54812,3898,11413,84014,04310,5863,2113,2113,0323,5913,0012,2932,1552,4602,064003,4033,17302,9052,3674,7835,2417,9271,4380001,358001,3001,2000001,300002,200
   > Long-term Liabilities 
1,800
0
0
2,000
0
0
0
3,100
3,000
0
0
3,180
0
0
0
2,358
0
0
0
3,365
0
0
0
4,174
0
0
4,207
4,281
5,350
5,419
4,675
17,323
14,208
12,477
12,477
5,525
5,548
6,988
11,867
12,801
13,457
15,008
19,327
20,554
20,703
22,426
21,455
21,819
22,261
21,926
19,556
23,060
22,675
27,096
26,367
26,537
21,849
19,638
19,554
18,888
17,500
25,310
22,692
21,294
88,250
92,110
0
72,448
87,535
111,370
98,312
85,169
66,317
78,927
76,617
78,470
86,512
120,160
0
0
98,324
139,680
151,967
140,992
115,557
93,723
83,656
81,158
177,622
165,077
156,245
149,137
151,846
149,906
151,088
144,651
143,322
132,258
133,426
134,262
147,317
147,431
147,545
148,021
121,872
115,053
115,053121,872148,021147,545147,431147,317134,262133,426132,258143,322144,651151,088149,906151,846149,137156,245165,077177,62281,15883,65693,723115,557140,992151,967139,68098,32400120,16086,51278,47076,61778,92766,31785,16998,312111,37087,53572,448092,11088,25021,29422,69225,31017,50018,88819,55419,63821,84926,53726,36727,09622,67523,06019,55621,92622,26121,81921,45522,42620,70320,55419,32715,00813,45712,80111,8676,9885,5485,52512,47712,47714,20817,3234,6755,4195,3504,2814,207004,1740003,3650002,3580003,180003,0003,1000002,000001,800
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
734
547
555
594
614
156
111,724
113,038
114,382
115,734
117,178
118,631
120,132
121,686
123,258
124,879
126,520
128,210
141,461
141,774
142,086
142,397
116,525
108,074
108,074116,525142,397142,086141,774141,461128,210126,520124,879123,258121,686120,132118,631117,178115,734114,382113,038111,7241566145945555477340000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,342
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000010,34200000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
246
246
226
1,788
1,344
0
1,528
3,259
0
0
2,834
2,741
3,789
3,822
3,088
15,387
0
10,484
2,077
3,147
3,023
4,544
7,974
9,838
10,615
12,241
16,672
17,487
17,666
19,403
18,341
19,375
19,683
19,233
17,119
20,695
20,421
24,741
23,902
23,527
19,041
16,783
17,730
17,208
0
0
0
19,354
0
23,329
0
12,200
23,974
24,360
25,123
9,827
9,626
9,456
8,554
2,333
2,094
2,206
0
96,289
120,151
138,892
151,233
140,445
115,002
93,129
83,042
81,002
65,898
52,039
41,863
43,378
30,779
27,658
28,090
20,646
17,859
5,292
4,938
4,212
4,139
4,068
3,999
3,917
3,847
5,716
5,7163,8473,9173,9994,0684,1394,2124,9385,29217,85920,64628,09027,65830,77943,37841,86352,03965,89881,00283,04293,129115,002140,445151,233138,892120,15196,28902,2062,0942,3338,5549,4569,6269,82725,12324,36023,97412,200023,329019,35400017,20817,73016,78319,04123,52723,90224,74120,42120,69517,11919,23319,68319,37518,34119,40317,66617,48716,67212,24110,6159,8387,9744,5443,0233,1472,07710,484015,3873,0883,8223,7892,7412,834003,2591,52801,3441,7882262462460000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,102
0
0
0
11,581
0
0
0
10,342
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000010,34200011,58100013,102000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
-1,500
0
0
23,100
0
0
0
14,300
11,400
0
0
17,785
0
0
0
9,067
2,543
13,729
11,938
10,882
9,607
0
7,848
7,509
0
0
11,958
12,286
11,069
10,641
20,479
92,061
94,006
92,773
92,773
116,757
116,953
105,107
94,525
86,654
82,495
79,374
71,920
73,026
68,018
58,985
55,432
54,627
57,324
56,860
50,663
48,546
49,044
49,953
50,070
44,863
38,910
32,364
33,468
36,305
34,019
31,894
32,363
29,794
31,985
25,361
0
30,504
21,682
-10,064
-15,405
-9,512
78,129
57,863
40,048
24,895
22,246
13,637
0
67,865
67,865
51,838
36,833
42,069
59,082
76,728
96,463
85,580
87,054
78,546
65,742
2,780
-9,582
-17,777
-26,963
-29,199
32,067
182,125
171,200
162,266
136,504
118,880
98,957
78,244
55,232
-3,332
-3,33255,23278,24498,957118,880136,504162,266171,200182,12532,067-29,199-26,963-17,777-9,5822,78065,74278,54687,05485,58096,46376,72859,08242,06936,83351,83867,86567,865013,63722,24624,89540,04857,86378,129-9,512-15,405-10,06421,68230,504025,36131,98529,79432,36331,89434,01936,30533,46832,36438,91044,86350,07049,95349,04448,54650,66356,86057,32454,62755,43258,98568,01873,02671,92079,37482,49586,65494,525105,107116,953116,75792,77392,77394,00692,06120,47910,64111,06912,28611,958007,5097,84809,60710,88211,93813,7292,5439,06700017,7850011,40014,30000023,10000-1,500
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
1,984
0
0
0
1,984
1,988
2,366
2,366
2,366
2,366
0
2,366
2,366
0
0
2,366
2,366
2,366
2,384
2,779
3,081
3,085
3,088
3,088
3,135
3,290
3,398
3,427
3,436
3,447
3,452
3,452
3,480
3,480
3,488
3,488
3,490
3,493
3,493
3,500
3,516
3,516
3,519
3,519
3,540
3,540
3,553
3,553
3,589
3,589
3,589
3,589
3,641
3,673
3,673
0
3,714
3,714
3,722
3,722
3,746
5,888
5,933
5,998
6,188
6,196
6,229
0
6,331
6,331
6,331
6,331
414
414
414
414
414
420
421
424
427
427
427
428
429
518
635
582
583
584
584
586
586
590
590
5905905865865845845835826355184294284274274274244214204144144144144146,3316,3316,3316,33106,2296,1966,1885,9985,9335,8883,7463,7223,7223,7143,71403,6733,6733,6413,5893,5893,5893,5893,5533,5533,5403,5403,5193,5193,5163,5163,5003,4933,4933,4903,4883,4883,4803,4803,4523,4523,4473,4363,4273,3983,2903,1353,0883,0883,0853,0812,7792,3842,3662,3662,366002,3662,36602,3662,3662,3662,3661,9881,9840001,98400000000000
   Retained Earnings -537,624-474,180-447,756-425,455-403,453-383,872-384,187-372,909-361,206-392,080-391,215-388,476-379,612-371,007-357,989-294,130-278,359-274,921-262,685-254,440-276,119-305,046-319,800-324,534-304,540-279,793-279,7930-326,205-308,805-320,452-293,303-283,257-262,184-235,546-240,668-234,304-201,450-192,6210-195,298-189,381-189,393-187,302-189,005-185,546-180,619-183,297-179,958-175,668-171,644-165,947-162,565-159,015-160,205-157,479-155,175-151,817-148,121-142,184-133,078-119,445-110,384-104,527-94,312-84,844-75,183-68,735-56,851-47,663-47,806-57,133-57,133-55,578-59,875-61,573-59,704-58,054-56,381-56,05400-59,386000-56,512000-47,051000-40,35700-35,000-32,500000-25,70000-20,300
   Accumulated Other Comprehensive Income 
-5,300
0
0
-5,700
0
0
0
-5,500
-5,500
0
0
-6,807
0
0
0
-6,962
0
0
0
-7,514
0
0
0
0
0
0
0
-4,877
-4,421
-3,893
-2,936
1,176
-1,329
-1,201
-1,201
13,039
5,509
-804
-834
-2,719
-549
3,576
3,404
6,451
7,314
8,383
11,372
14,085
18,395
18,686
13,556
12,150
0
13,137
15,042
14,469
11,654
8,192
11,641
10,873
12,978
13,584
11,379
10,057
10,936
9,384
0
10,253
9,769
10,112
10,539
10,815
10,047
8,790
-2,324
-7,423
-23,716
-18,810
0
-23,000
-22,657
-18,850
-19,688
-23,565
-23,391
-22,680
-23,421
-23,266
-23,255
-23,659
-23,651
-23,416
-23,203
-22,848
-22,972
-22,806
-23,627
-22,518
-21,918
-21,051
-22,306
-22,350
-22,744
-23,940
-25,042
-26,328
-26,328-25,042-23,940-22,744-22,350-22,306-21,051-21,918-22,518-23,627-22,806-22,972-22,848-23,203-23,416-23,651-23,659-23,255-23,266-23,421-22,680-23,391-23,565-19,688-18,850-22,657-23,0000-18,810-23,716-7,423-2,3248,79010,04710,81510,53910,1129,76910,25309,38410,93610,05711,37913,58412,97810,87311,6418,19211,65414,46915,04213,137012,15013,55618,68618,39514,08511,3728,3837,3146,4513,4043,576-549-2,719-834-8045,50913,039-1,201-1,201-1,3291,176-2,936-3,893-4,421-4,8770000000-7,514000-6,962000-6,80700-5,500-5,500000-5,70000-5,300
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
363,984
366,459
368,897
374,724
385,020
387,105
389,451
391,416
393,478
427,383
430,141
433,097
433,756
434,199
434,254
434,055
434,391
497,249
615,207
565,440
566,916
542,093
544,094
546,565
549,349
553,859
560,025
560,025553,859549,349546,565544,094542,093566,916565,440615,207497,249434,391434,055434,254434,199433,756433,097430,141427,383393,478391,416389,451387,105385,020374,724368,897366,459363,9840000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000-49,998-49,998-49,998-49,998-49,998-49,998-49,998-49,998-49,998-42,573-22,361-17,506-14,3380000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
24,100
0
0
54,500
0
0
0
52,300
51,900
0
0
62,965
0
0
0
61,096
0
0
0
72,542
0
0
0
64,529
0
0
65,646
71,178
71,178
71,854
82,209
147,679
147,828
148,019
148,019
148,389
155,817
159,364
160,667
161,120
164,441
166,658
169,591
173,479
176,669
180,192
182,756
185,173
187,253
189,856
191,086
193,085
204,543
195,862
197,456
198,498
199,384
200,577
201,571
202,462
202,998
203,726
204,697
205,489
206,757
207,602
0
209,158
209,649
210,406
211,002
211,473
324,378
326,397
329,677
346,582
348,571
352,423
0
-22,657
363,984
368,897
374,724
385,020
387,105
375,113
373,910
371,117
384,810
380,143
383,099
383,758
384,201
384,256
384,057
384,393
447,251
565,209
565,440
566,916
542,093
544,094
546,565
549,940
553,859
560,620
560,620553,859549,940546,565544,094542,093566,916565,440565,209447,251384,393384,057384,256384,201383,758383,099380,143384,810371,117373,910375,113387,105385,020374,724368,897363,984-22,6570352,423348,571346,582329,677326,397324,378211,473211,002210,406209,649209,1580207,602206,757205,489204,697203,726202,998202,462201,571200,577199,384198,498197,456195,862204,543193,085191,086189,856187,253185,173182,756180,192176,669173,479169,591166,658164,441161,120160,667159,364155,817148,389148,019148,019147,828147,67982,20971,85471,17871,17865,6460064,52900072,54200061,09600062,9650051,90052,30000054,5000024,100



Balance Sheet

Currency in USD. All numbers in thousands.